REGENXBIO · 19 hours ago
Director, Regulatory Affairs
REGENXBIO is an exceptional place to work, focusing on innovative gene therapy products. As the Director of Regulatory Affairs, you will develop and execute global regulatory strategies, ensuring compliance with U.S. and international requirements while engaging with stakeholders and contributing to industry workgroups.
BiopharmaBiotechnologyGeneticsTherapeutics
Responsibilities
Develop regulatory strategies for new products and prepare and submit all necessary applications, reports, and correspondence to regulatory agencies
Monitor global and local regulatory environments affecting approval of advanced therapies and products of interest to REGENXBIO
Anticipate the impact of the changing domestic and international regulatory environment on development plans, registrational strategies, and post-marketing responsibilities
Build internal dashboard of regulatory science and policy resources including guidance documents, relevant regulatory decisions, and other content
Partner with the Regulatory Function to ensure regulatory strategy and execution for pipeline products in early-stage development are well aligned
Travel up to 20% of the time is required
Qualification
Required
Doctorate level or masters required (MD or PhD, MS in Science/Biotechnology/Regulatory or equivalent) with at least 10 years of relevant experience required
Demonstrated ability to lead and motivate people
Ability to proactively predict issues and solve problems
Flexible, resilient, resourceful, entrepreneurial, innovative, and conducts all activities in a highly ethical manner
Experience with global regulatory quality requirements
Proactive approaches to problem-solving with strong decision-making capability
Strong written and oral communication skills; comfortable communicating with and building relationships with various stakeholders including external partners and health authorities
Travel up to 20% of the time is required
Preferred
Familiarity with regulatory requirements in the United States and other regions
Experience in gene therapy
Experience with preparation of high-quality FDA/EMA submission documentation and Health Authority meeting preparations
Benefits
Market-competitive salaries
Annual bonus program
Education assistance
Retirement plan with employer match
Stock options at all levels
Summer hours
Company
REGENXBIO
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Funding
Current Stage
Public CompanyTotal Funding
$928.19MKey Investors
Vivo Capital
2025-05-19Post Ipo Debt· $150M
2024-03-06Post Ipo Equity· $140M
2021-01-06Post Ipo Equity· $230.3M
Leadership Team
Recent News
2026-01-16
Longevity.Technology
2026-01-16
Company data provided by crunchbase